Conference item
Safety and tumour hypoxia modifying effect of buparlisib with radiotherapy in NSCLC: a phase I dose escalation study
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 125.0KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.jtho.2018.08.888
Authors
- Publisher:
- Elsevier
- Host title:
- Journal of Thoracic Oncology
- Journal:
- IASLC 19th World Conference on Lung Cancer More from this journal
- Volume:
- 13
- Issue:
- 10
- Pages:
- S594
- Publication date:
- 2018-10-22
- Acceptance date:
- 2018-06-22
- Event location:
- Toronto, Canada
- Event start date:
- 2018-09-23
- Event end date:
- 2018-09-26
- DOI:
- EISSN:
-
1556-1380
- ISSN:
-
1556-0864
- Keywords:
- Pubs id:
-
pubs:859215
- UUID:
-
uuid:f12dcafd-9d19-4ea7-bbca-190452663526
- Local pid:
-
pubs:859215
- Source identifiers:
-
859215
- Deposit date:
-
2018-06-25
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2018
- Notes:
- © 2018 Published by Elsevier Inc. This is a conference paper presented at the IASLC 19th World Conference on Lung Cancer September 23-26 2018, Toronto, Canada. This is the accepted manuscript version of the paper. The final version is available online from Elsevier at: https://doi.org/10.1016/j.jtho.2018.08.888
If you are the owner of this record, you can report an update to it here: Report update to this record